Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?
第一作者:
Lizza E L,Hendriks
第一单位:
Dept. of Pulmonary Diseases, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, PO Box 5800, 6202 AZ Maastricht, The Netherlands. Electronic address: lizza.hendriks@mumc.nl.
作者:
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);脑(Brain);脑肿瘤(Brain Neoplasms);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);顺铂(Cisplatin);综合疗法(Combined Modality Therapy);依托泊甙(Etoposide);女(雌)性(Female);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);回顾性研究(Retrospective Studies);危险因素(Risk Factors);存活率分析(Survival Analysis);紫杉烷类(Taxoids);治疗结果(Treatment Outcome);长春碱(Vinblastine)
DOI
10.1016/j.lungcan.2016.09.008
PMID
27794410
发布时间
2019-10-27
- 浏览43
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文